The global in-vitro diagnostics (IVD) market size was valued at USD 73.99 billion in 2024. The market is expected to grow from USD 77.73 billion in 2025 to USD 117.60 billion by 2032, exhibiting a CAGR of 6.1% during the forecast period. North america dominated the in-vitro diagnostics (ivd) market with a market share of 37.71% in 2024.

Market Overview

The in vitro diagnostics market ****is experiencing transformative growth, driven by healthcare technology innovations, expanding digital ecosystems, and a rising focus on preventive and personalized medicine. Between 2024  and 2032, the industry is projected to expand significantly, supported by higher healthcare budgets, evolving patient expectations, and growing investments in infrastructure and research.

Demographic shifts—including aging populations, urbanization, and the rising prevalence of chronic diseases—are further accelerating demand for advanced healthcare services and solutions worldwide.

in vitro diagnostics market represents a broad set of products, solutions, and services that enhance care delivery, improve safety, and ensure compliance. These solutions are crucial for reducing risks, protecting patients, enhancing diagnostic and treatment efficiency, and maintaining regulatory adherence.

Continue reading for more details:

https://www.fortunebusinessinsights.com/in-vitro-diagnostics-market-101443

Key Market Drivers

  1. Rising Patient Safety Concerns – Demand for tools that prevent medical errors and infections.
  2. Technological Advancements – Integration of AI, analytics, and automation for efficiency.
  3. Healthcare Expenditure Growth – Investments in infrastructure upgrades by governments and private players.
  4. Regulatory Pressure – Strict global safety standards driving adoption.
  5. Expansion in Emerging Markets – Improved healthcare infrastructure in Asia-Pacific, Latin America, and Africa.

Market Segmentation

The in vitro diagnostics market can be segmented as follows:

  1. Market Analysis, Insights and Forecast – By Product Type
    1. Instruments
    2. Reagents & Consumables
  2. Market Analysis, Insights and Forecast – By Technique
    1. Immunodiagnostics
      1. Enzyme-linked immunosorbent Assays (ELISA)
      2. Fluorescence immunoassay (FIA)
      3. Rapid test
      4. Others
    2. Clinical Chemistry
      1. Electrolyte Panel
      2. Basic and Comprehensive Metabolic Panels
      3. Liver Tests
      4. Renal Tests
      5. Lipid Panel
      6. Others
    3. Molecular Diagnostics
      1. Polymerase Chain Reaction (PCR)
      2. In Situ Hybridization
      3. DNA Sequencing & Next-Generation Sequencing
      4. Others
    4. Hematology
    5. Others
  3. Market Analysis, Insights and Forecast – By Sample Type
    1. Blood
    2. Urine
    3. Saliva
    4. Tissue
    5. Others
  4. Market Analysis, Insights and Forecast – By Setting
    1. Laboratories
    2. Point of care